Physician profile
Leonard Lev
NPI 1033287982
$1,872.63
in general payments reported to CMS, 2019-2025
13 companies · $660 in 2025
The $660 reported for 2025 was more than what 75% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $41.11 · 2021: $23.25 · 2022: $244 · 2023: $318 · 2024: $320 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $450.22 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $288.55 | 2022-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Allergan, INC. | $261.14 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $177.74 | 2022-2024 | Ingrezza |
| Alkermes, INC. | $166.51 | 2019-2023 | Aristada, Aristada Initio |
| Indivior INC. | $122.77 | 2025 | Sublocade |
| Janssen Pharmaceuticals, INC | $120.12 | 2022 | |
| Axsome Therapeutics, INC. | $107.23 | 2023-2024 | Auvelity |
| Lundbeck LLC | $81.24 | 2022-2024 | Rexulti |
| Brainsway USA INC | $50.23 | 2025 | Deep Tms System |
| Novo Nordisk INC | $18.01 | 2022 | |
| Orexo US, INC. | $16.44 | 2019 | |
| Currax Pharmaceuticals LLC | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Lev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.